Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
WPP client Dell Technologies is rolling out its global in-housing initiative, reshaping media-buying strategy
The technology giant is evolving its media model in a manner that will alter its relationships with third-parties.
In the face of fragmentation, Dmexco is now a smaller stage for ad tech’s big conversations
These days, it’s still where business gets done, but increasingly for a narrower slice of the ecosystem.
When it comes to Perplexity’s ad business, the platform is at a crossroads
The departure of Perplexity’s ads chief Taz Patel underscores a broader identity question the AI platform has yet to resolve.